News: Regeneus closes $3M private placement, page-7

I disagree on this comment. The therapy works and has been proven, studied and now positive historical data is being reported. Your post is inaccurate as the core of RGS has been trialled & PROVEN - it's in the market for public use.

I am critical of this stock for other reasons, some indirectly to your comment. If RGS had better marketing it would be recognised for what it does and sufferers would know about it and use it. We also wouldn't have comments from people thinking the core technology is in trial phase. Perfect case in point if you ask me.